Ebele Ola
Ebele Ola serves as the vice-president of clinical, medical, and regulatory affairs at Novo Nordisk Canada, where she emphasizes the ongoing commitment to the semaglutide molecule and its potential impact on healthcare.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Ebele Ola, Novo Nordisk Canada’s vice-president of clinical, medical and regulatory affairs, expressed commitment to the semaglutide molecule.
8